Sarepta Therapeutics (SRPT) Enterprise Value (QoQ) (2010 - 2026)

Sarepta Therapeutics (SRPT) Enterprise Value (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Sarepta Therapeutics 1.66 Bn 1.25 Bn 622.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 56.84%
Dec 31, 2025 -46.26%
Sep 30, 2025 -45.09%
Jun 30, 2025 15.29%
Mar 31, 2025 52.30%
Dec 31, 2024 -351.99%
Sep 30, 2024 83.40%
Jun 30, 2024 -5.01%
Mar 31, 2024 17.03%
Dec 31, 2023 3.30%
Sep 30, 2023 6.83%
Jun 30, 2023 1.14%
Mar 31, 2023 5.39%
Dec 31, 2022 4.01%
Sep 30, 2022 -7.49%
Jun 30, 2022 4.24%
Mar 31, 2022 4.84%
Dec 31, 2021 -32.32%
Sep 30, 2021 7.42%
Jun 30, 2021 0.61%